High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.
暂无分享,去创建一个
Reino Laatikainen | Jari Laurikka | Terho Lehtimäki | Mika Kähönen | Pasi Soininen | Mika Ala-Korpela | Russell Thomson | Tuulia Tynkkynen | Antti J Kangas | Olli T Raitakari | Pekka Kuukasjärvi | T. Lehtimäki | J. Viikari | O. Raitakari | A. Jula | M. Kähönen | M. Savolainen | R. Thomson | P. Soininen | A. Kangas | M. Ala-Korpela | C. Magnussen | M. Juonala | P. Würtz | Tuulia Tynkkynen | R. Laatikainen | P. Karhunen | Peter Würtz | Antti Jula | M. Tarkka | Markus Juonala | Matti Tarkka | Jorma S Viikari | J. Laurikka | P. Kuukasjärvi | Costan G Magnussen | Markku J Savolainen | Juho R Raiko | Pekka J Karhunen | J. Raiko | M. Kähönen
[1] Reino Laatikainen,et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.
[2] Mika Ala-Korpela,et al. Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics , 2008, Clinical chemistry and laboratory medicine.
[3] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[4] S. Mora. Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use. , 2009, Circulation.
[5] Brian J. Bennett,et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.
[6] Kimmo Kaski,et al. Detailed metabolic and genetic characterization reveals new associations for 30 known lipid loci. , 2012, Human molecular genetics.
[7] Luigi Atzori,et al. Metabolomics as a tool for cardiac research , 2011, Nature Reviews Cardiology.
[8] J. Lau,et al. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. , 2006, Atherosclerosis.
[9] M. Tobin,et al. Coronary Artery Disease–Associated Locus on Chromosome 9p21 and Early Markers of Atherosclerosis , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[10] Markus Perola,et al. Metabonomic, transcriptomic, and genomic variation of a population cohort , 2010, Molecular systems biology.
[11] D. Harrison,et al. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. , 1995, The Journal of clinical investigation.
[12] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2003, Circulation.
[13] Michael J Pencina,et al. Carotid-wall intima-media thickness and cardiovascular events. , 2011, The New England journal of medicine.
[14] Nancy R Cook,et al. Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures , 2009, Annals of Internal Medicine.
[15] H. Superko. Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful , 2009, Circulation.
[16] P. Calder,et al. Cardiovascular effects of marine omega-3 fatty acids , 2010, The Lancet.
[17] Edward A Dennis,et al. The human plasma lipidome. , 2011, The New England journal of medicine.
[18] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[19] E. DeLong,et al. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.
[20] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[21] T. Lehtimäki,et al. Characterization of systemic metabolic phenotypes associated with subclinical atherosclerosis. , 2011, Molecular bioSystems.
[22] Svati H Shah,et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. , 2009, Cell metabolism.
[23] S. Grundy,et al. National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .
[24] Risto Telama,et al. Cohort profile: the cardiovascular risk in Young Finns Study. , 2008, International journal of epidemiology.
[25] R. Krauss,et al. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. , 1997, Circulation.
[26] T. Lehtimäki,et al. Diagnostic performance of plasma high sensitive C‐reactive protein in detecting three‐vessel coronary artery disease: modification by apolipoprotein E genotype , 2008, Scandinavian journal of clinical and laboratory investigation.
[27] Geoffrey S Ginsburg,et al. Association of a Peripheral Blood Metabolic Profile With Coronary Artery Disease and Risk of Subsequent Cardiovascular Events , 2010, Circulation. Cardiovascular genetics.
[28] J. Lau,et al. Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes , 2009, Annals of Internal Medicine.
[29] Terho Lehtimäki,et al. Conventional Cardiovascular Risk Factors and Metabolic Syndrome in Predicting Carotid Intima-Media Thickness Progression in Young Adults: The Cardiovascular Risk in Young Finns Study , 2009, Circulation.
[30] Matthias W. Lorenz,et al. Prediction of Clinical Cardiovascular Events With Carotid Intima-Media Thickness: A Systematic Review and Meta-Analysis , 2007, Circulation.
[31] D. Levy,et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. , 2006, The New England journal of medicine.
[32] T. Laitinen,et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.
[33] D. Lloyd‐Jones,et al. Cardiovascular risk prediction: basic concepts, current status, and future directions. , 2010, Circulation.
[34] Samia Mora,et al. Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women , 2009, Circulation.
[35] V. Mootha,et al. Metabolite profiles and the risk of developing diabetes , 2011, Nature Network Boston.
[36] W D Wagner,et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.
[37] M. Pencina,et al. Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. , 2009, JAMA.
[38] T. Laitinen,et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study. , 2008, Journal of the American College of Cardiology.
[39] Ian D. Wilson,et al. Metabolic Phenotyping in Health and Disease , 2008, Cell.
[40] Thomas J. Wang,et al. Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction , 2011, Circulation.
[41] Olli Saarela,et al. Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project , 2010, Circulation.
[42] David W. Hosmer,et al. Applied Logistic Regression , 1991 .